HMA Guide to Managing Declarations of Interest

The Heads of Medicines Agencies (HMA), which is part of the European medicines regulatory network, is increasingly harmonising the way National Competent Authorities (NCAs) do their work.

As part of this process it has published this guidance with a view to forming a unified approach to the management of conflicts of interests across member states.

The guidelines are intended to assist the NCAs, which together form the HMA, to effectively manage declarations of interest so that they can ensure the highest possible common standards of impartiality and independence.

HMA Guide to Managing Declarations of Interest | pdf, adopted November 2014